The Advisory Board Company (NASDAQ:ABCO)

CAPS Rating: 2 out of 5

The Company provides best practices research, decision support tools and analysis to the health care industry in the United States.

Recs

0
Player Avatar MMCapitalMgmt (99.82) Submitted: 1/4/2013 2:32:47 PM : Underperform Start Price: $49.89 ABCO Score: +3.47

Ridiculously overvalued. Trading at 25x EV/EBITDA, 4x EV/Rev, 7x book value, 4x sales, 64x trailing earnings, 33x forward earnings.Come on now, this isn't a premium company.

Featured Broker Partners


Advertisement